Top ▲
Target id: 3069
Nomenclature: Plasmodium falciparum hexose transporter
Abbreviated Name: PfHT1
Family: Transporters (Plasmodium spp.)
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Plasmodium falciparum 3D7 | - | 504 | HT1 | hexose transporter | ||
Gene and Protein Information Comments | ||||||
PfHT1 is the single annotated hexose transporter in the Plasmodium genome. It is a member of the SLC2 family of hexose and sugar alcohol transporters but is highly divergent in sequence from all human orthologs with GLUT1, the most closely related human ortholog, sharing <30% amino acid identity with PfHT1 [3-4]. |
Previous and Unofficial Names |
HT1 | Pf3D7_02_v3:204,784..207,425(-) | hexose transporter 1 | HT | PF02_0044 | PFB0210c |
Database Links | |
Alphafold | Q7KWJ5 (Pf3D7) |
PlasmoDB | PF3D7_0204700 (Pf3D7) |
UniProtKB | Q7KWJ5 (Pf3D7) |
Selected 3D Structures | |||||||||||
|
|||||||||||
|
|||||||||||
|
Whole Organism Assay Data Linked to This Target | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Malaria Pharmacology Comments |
The P. falciparum hexose transporter (PfHT1) mediates glucose uptake, an essential process because the intraerythrocytic stages of the parasite's lifecycle are dependent upon host glucose for energy [6]. PfHT1 shows promise as a target for antimalarial drug development with a focus on identifying compounds that inhibit the parasite permease without impairing function of human SLC2 transporters. It is a target "under consideration" in the Malaria Drug Accelerator (MalDA) portfolio [1]. Studies using a structure-guided design approach have identified small molecules that selectively target PfHT1 and simultaneously bind both orthosteric and allosteric pockets of the transporter [2-3]. These PfHT1 inhibitors lack many of the drug-like properties required for clinical advancement but will help inform future drug discovery efforts. |
1. Forte B, Ottilie S, Plater A, Campo B, Dechering KJ, Gamo FJ, Goldberg DE, Istvan ES, Lee M, Lukens AK et al.. (2021) Prioritization of Molecular Targets for Antimalarial Drug Discovery. ACS Infect Dis, 7 (10): 2764-2776. [PMID:34523908]
2. Huang J, Yuan Y, Zhao N, Pu D, Tang Q, Zhang S, Luo S, Yang X, Wang N, Xiao Y et al.. (2021) Orthosteric-allosteric dual inhibitors of PfHT1 as selective antimalarial agents. Proc Natl Acad Sci U S A, 118 (3). [PMID:33402433]
3. Jiang X, Yuan Y, Huang J, Zhang S, Luo S, Wang N, Pu D, Zhao N, Tang Q, Hirata K et al.. (2020) Structural Basis for Blocking Sugar Uptake into the Malaria Parasite Plasmodium falciparum. Cell, 183 (1): 258-268.e12. [PMID:32860739]
4. Ortiz D, Guiguemde WA, Johnson A, Elya C, Anderson J, Clark J, Connelly M, Yang L, Min J, Sato Y et al.. (2015) Identification of Selective Inhibitors of the Plasmodium falciparum Hexose Transporter PfHT by Screening Focused Libraries of Anti-Malarial Compounds. PLoS ONE, 10 (4): e0123598. [PMID:25894322]
5. Qureshi AA, Suades A, Matsuoka R, Brock J, McComas SE, Nji E, Orellana L, Claesson M, Delemotte L, Drew D. (2020) The molecular basis for sugar import in malaria parasites. Nature, 578 (7794): 321-325. [PMID:31996846]
6. Woodrow CJ, Penny JI, Krishna S. (1999) Intraerythrocytic Plasmodium falciparum expresses a high affinity facilitative hexose transporter. J Biol Chem, 274 (11): 7272-7. [PMID:10066789]
Transporters (Plasmodium spp.): Plasmodium falciparum hexose transporter. Last modified on 11/12/2021. Accessed on 04/12/2024. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetomalariapharmacology.org/GRAC/ObjectDisplayForward?objectId=3069.